Stocktoria
ACHIEVE LIFE SCIENCES, INC. ACHV
ACHIEVE LIFE SCIENCES, INC. (ACHV) earns a Piotroski F-score of 1/9 (weak financial health). It does not currently pay a dividend.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 1/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| ACHV | ACHIEVE LIFE SCIENCES, INC. | 1/9 | — | — | — |
| IDXX | IDEXX LABORATORIES INC /DE | 8/9 | 10.43 | 41.1 | +10.4% |
| QDEL | QuidelOrtho Corp | 5/9 | -0.56 | — | -1.9% |
| LNTH | Lantheus Holdings, Inc. | 4/9 | 4.61 | 30.6 | +0.5% |
| NEOG | NEOGEN CORP | 4/9 | -0.23 | — | -2.7% |
| MYGN | MYRIAD GENETICS INC | 5/9 | -5.88 | — | -1.6% |
| NTLA | Intellia Therapeutics, Inc. | 2/9 | -6.12 | — | +16.9% |
About ACHIEVE LIFE SCIENCES, INC.
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
FAQ
Is ACHV financially healthy?
ACHIEVE LIFE SCIENCES, INC.'s Piotroski F-score is 1/9 (8–9 is excellent, 0–3 weak).
Does ACHV pay a dividend?
No, ACHIEVE LIFE SCIENCES, INC. does not currently pay a dividend.
How profitable is ACHV?
In FY2025, ACHIEVE LIFE SCIENCES, INC. had a return on equity of -254.0%.
What is the analyst price target for ACHV?
The average Wall-Street price target for ACHIEVE LIFE SCIENCES, INC. is $13.80, about 106.3% above the recent price, from 10 analysts (consensus: strong buy).
Is ACHV a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on ACHIEVE LIFE SCIENCES, INC.: a Piotroski F-score of 1/9. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.